For a current compounder or someone looking to enter the space, it is imperative that their business remains on top of the latest compounding developments.
Tera Lynn A. Rule, PharmD, JD, RPh, Esq
Advertisement
Articles by Tera Lynn A. Rule, PharmD, JD, RPh, Esq
Advertisement
Latest Updated Articles
Actions Following the FDA Compounding Priorities PlanPublished: January 22nd 2019 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Evolving Mortality Trends in Heart Failure and Vascular Disease: The Critical Role of Pharmacists in Addressing Cardiovascular Risk
2
Targeting Mitochondrial Metabolism in Heart Failure: From Genetic Drivers to Fuel Modulation Therapies
3
Eli Lilly, Novo Nordisk Strike MFN Deals With Trump Administration to Lower GLP-1 Prices
4
SGLT2 Inhibitors Linked to Lower Atrial Fibrillation Risk, Recurrence
5
